Additional Product Education

Please fill out the form below to download the webinar on GI-Map™ DNA Stool Analysis.

DSL GI-MAPTM Webinar Download

  • Home
  • Diagnostic Solutions Laboratory
GiRevive.png

Multiplex DNA Stool Technology for the Integrative and Functional Medicine Practitioner

The GI-MAP™ is the first comprehensive stool analysis to include an FDA-approved DNA/PCR assay for GI pathogens performed on stool**. The pathogen targets include bacteria, parasites and another first for the market, viruses!


Using the same molecular technology, we have developed assays for microbes that are useful for integrative and function medicine practitioners. And unlike previous PCR assays, we have fully validated each target organism in our panel, so that you can have confidence in the results.

GI-MAP™ tests for GI pathogens, opportunistic organisms, normal flora, and markers of GI health including:

  • Bacteria
  • Viruses
  • Parasites
  • Fungi
  • Inflammation
  • Immune function
  • Pancreatic function
  • Occult blood
GI Map Image

DNA/PCR techniques also allow for the measurement of antibiotic resistance genes and virulence factors that contribute to pathogenicity. Both are used to help determine clinical significance and the most effective treatments.


Other available stool tests may appear to be DNA-based tests, but they are in fact only using Matrix Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) to identify stool microbes. Their methodology relies on cultures from stool and is not molecular/PCR based assays. With a culture based test it is not possible to measure strict anaerobes, viruses or virulence factors. They also lack the ability to deliver true quantitation of any of the reported organisms.


Other recent test offerings using an FDA-cleared molecular technology only for pathogens does not extend any molecular methodology over an entire comprehensive stool analysis, to include opportunistic and beneficial organisms, including bacteria, protozoa, and fungi, like the GI-MAP™ provides.


There have been many advances in DNA technology over the last 10 years, including an FDA approved, PCR based technology and assay that is used by major hospital labs. Considering these advances, why would you still rely on culture and microscopy for stool analysis and assessment of the GI environment?


We have the solution. A truly Diagnostic Solution!

Click here for a free white paper on GI-MAP™ DNA Stool Analysis

Click Here

Fill out a form to request more information on the GI-MAP™ from your Health Educator


Click Here

** GI pathogens are performed using the Luminex GGP assay developed and patented by Luminex Corporation.

DSL GIMAP WhitePaper Download

DSL GI-Map HE Follow up